Injective Protocol
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.6m | Seed | ||
$10.0m Valuation: $1.0b | ICO | ||
* | $40.0m Valuation: $1.0b | Late VC | |
Total Funding | $42.6m |
Related Content
Recent News about Injective Protocol
EditInjective Protocol operates in the decentralized finance (DeFi) market, providing a fully decentralized cross-chain derivatives exchange. The platform allows users to create and trade on any financial market with low fees and high security, leveraging Tendermint-based proof of stake consensus for instant transaction finality. Injective serves a diverse range of clients, from novice traders to advanced financial professionals, offering a user-friendly interface that mimics the experience of centralized exchanges while maintaining decentralization. The business model revolves around transaction fees and token rewards, with additional revenue generated from market and limit orders on various listed assets. Injective also supports perpetual futures and spot markets, enhancing its appeal to a broad spectrum of traders. The company is community-governed, encouraging active participation from early adopters and stakeholders to shape the future of the platform.
Keywords: decentralized, cross-chain, derivatives, exchange, low-fee, secure, Tendermint, proof of stake, perpetual futures, community-governed.